Suzanne C Danhauer1, Mollie Canzona2, Reginald D Tucker-Seeley3, Bryce B Reeve4, Chandylen L Nightingale1, Dianna S Howard5, Nicole Puccinelli-Ortega1, Denisha Little-Greene1, John M Salsman1. 1. Department of Social Sciences & Health Policy, Wake Forest School of Medicine, Winston Salem, North Carolina, USA. 2. Department of Communication, Wake Forest University, Winston Salem, North Carolina, USA. 3. Leonard Davis School of Gerontology, University of Southern California, Los Angeles, California, USA. 4. Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina, USA. 5. Department of Internal Medicine, Section on Hematology and Oncology, Wake Forest School of Medicine, Winston Salem, North Carolina, USA.
Abstract
BACKGROUND: Cancer and its treatments can result in substantial financial burden that may be especially distressing for adolescents and young adults (AYAs) since they are at a developmental stage focused on completing one's education and establishing independence. The purpose of this study was to develop a conceptual model of financial burden among AYA cancer patients to inform development of a financial burden measure. METHODS: In-depth concept elicitation interviews were conducted with a purposive-selected stakeholder sample (36 AYAs and 36 AYA oncology health care providers). The constant comparative method was used to identify themes that illustrate AYAs' experience of financial burden by stakeholder groups. RESULTS: Eleven financial burden themes emerged: (1) impact of socioeconomic status and age; (2) significant cancer costs; (3) indirect cost "ripple effects"; (4) limited awareness of costs (adolescents); (5) emotional impact; (6) feeling overwhelmed navigating the health care system; (7) treatment decision modifications; (8) reducing spending; (9) coping strategies; (10) financial support; and (11) long-lasting impact. The conceptual model highlights the importance of material, psychosocial, and behavioral domains of financial burden with an emphasis on phase along the cancer continuum and developmental stage in the experience of financial burden for AYAs. CONCLUSIONS: Issues presented in the voice of AYA patients and providers highlight the profound impact of financial burden in this survivor group. The next step in this work will be to develop and test a patient-reported measure of financial burden among AYA cancer survivors.
BACKGROUND: Cancer and its treatments can result in substantial financial burden that may be especially distressing for adolescents and young adults (AYAs) since they are at a developmental stage focused on completing one's education and establishing independence. The purpose of this study was to develop a conceptual model of financial burden among AYA cancer patients to inform development of a financial burden measure. METHODS: In-depth concept elicitation interviews were conducted with a purposive-selected stakeholder sample (36 AYAs and 36 AYA oncology health care providers). The constant comparative method was used to identify themes that illustrate AYAs' experience of financial burden by stakeholder groups. RESULTS: Eleven financial burden themes emerged: (1) impact of socioeconomic status and age; (2) significant cancer costs; (3) indirect cost "ripple effects"; (4) limited awareness of costs (adolescents); (5) emotional impact; (6) feeling overwhelmed navigating the health care system; (7) treatment decision modifications; (8) reducing spending; (9) coping strategies; (10) financial support; and (11) long-lasting impact. The conceptual model highlights the importance of material, psychosocial, and behavioral domains of financial burden with an emphasis on phase along the cancer continuum and developmental stage in the experience of financial burden for AYAs. CONCLUSIONS: Issues presented in the voice of AYA patients and providers highlight the profound impact of financial burden in this survivor group. The next step in this work will be to develop and test a patient-reported measure of financial burden among AYA cancer survivors.
Authors: Janine Vetsch; Claire E Wakefield; Brittany C McGill; Richard J Cohn; Sarah J Ellis; Natalie Stefanic; Susan M Sawyer; Brad Zebrack; Ursula M Sansom-Daly Journal: Psychooncology Date: 2017-09-11 Impact factor: 3.894
Authors: John M Salsman; Suzanne C Danhauer; Justin B Moore; Mollie R Canzona; David E Victorson; Bradley J Zebrack; Bryce B Reeve Journal: Cancer Date: 2020-09-10 Impact factor: 6.860
Authors: Kathryn Eilene Lasch; Patrick Marquis; Marc Vigneux; Linda Abetz; Benoit Arnould; Martha Bayliss; Bruce Crawford; Kathleen Rosa Journal: Qual Life Res Date: 2010-05-30 Impact factor: 4.147
Authors: K Robin Yabroff; Emily C Dowling; Gery P Guy; Matthew P Banegas; Amy Davidoff; Xuesong Han; Katherine S Virgo; Timothy S McNeel; Neetu Chawla; Danielle Blanch-Hartigan; Erin E Kent; Chunyu Li; Juan L Rodriguez; Janet S de Moor; Zhiyuan Zheng; Ahmedin Jemal; Donatus U Ekwueme Journal: J Clin Oncol Date: 2015-12-07 Impact factor: 44.544
Authors: Austin R Waters; Sara Bybee; Echo L Warner; Heydon K Kaddas; Erin E Kent; Anne C Kirchhoff Journal: Front Oncol Date: 2022-06-16 Impact factor: 5.738
Authors: Chandylen L Nightingale; Mollie R Canzona; Suzanne C Danhauer; Bryce B Reeve; Dianna S Howard; Reginald D Tucker-Seeley; Shannon L S Golden; Denisha Little-Greene; Michael E Roth; David E Victorson; John M Salsman Journal: Psychooncology Date: 2022-04-20 Impact factor: 3.955